An Inducible Transgene Expression System for Regulated Phenotypic Modification of Human Embryonic Stem Cells

Stem Cell Program, University of California, Davis, CA 95616, USA.
Stem Cells and Development (Impact Factor: 3.73). 05/2008; 17(2):315-24. DOI: 10.1089/scd.2007.0114
Source: PubMed


Self-renewing pluripotent human embryonic stem (hES) cells are capable of regenerating such non-dividing cells as neurons and cardiomyocytes for therapies and can serve as an excellent experimental model for studying early human development. Both the spatial and temporal relationships of gene expression play a crucial role in determining differentiation; to obtain a better understanding of hES cell differentiation, it will be necessary to establish an inducible system in hES cells that enables specific transgene(s) to reversibly and conditionally express (1) at specific levels and (2) at particular time points during development. Using lentivirus (LV)-mediated gene transfer and a tetracycline-controlled trans-repressor (TR), we first established in hES cells a doxycycline (DOX)-inducible expression system of green fluorescent protein (GFP) to probe its reversibility and kinetics. Upon the addition of DOX, the percentage of GFP(+) hES cells increased time dependently: The time at which 50% of all green cells appeared (T(50)(on)) was 119.5+/-3.2 h; upon DOX removal, GFP expression declined with a half-time (T(50)(off)) of 127.7+/-3.9 h and became completely silenced at day 8. Both the proportion and total mean fluorescence intensity (MFI) were dose-dependent (EC(50)=24.5+/-2.2 ng/ml). The same system when incorporated into murine (m) ES cells similarly exhibited reversible dose-dependent responses with a similar sensitivity (EC(50)=49.5+/-8.5 ng/ml), but the much faster kinetics (T(50)(on)=35.5+/-5.5 h, T(50)(off) = 71.5+/-2.4 hours). DOX-induced expression of the Kir2.1 channels in mES and hES cells led to robust expression of the inwardly rectifying potassium (K(+)) current and thereby hyperpolarized the resting membrane potential (RMP). We conclude that the LV-inducible system established presents a unique tool for probing differentiation.

Download full-text


Available from: Yunjoon Jung, Jun 30, 2015
  • Source
    • "Contractile apparatus and myofilaments even deteriorate, probably due to the lack of spontaneous contractions after silencing. Indeed, immature Ca2+ transient properties of hESC-CMs can be attributed to the differential developmental expression profiles of Ca2+-handling proteins [52,53]. In a separate study, forced expression of calsequestrin improves Ca2+ transients in hESC-CMs by significantly increasing the transient amplitude, upstroke, and decay velocities as well as the sarcoplasmic reticulum content, but without altering ICa,L, suggesting the improved transient is not simply due to a higher Ca2+ influx [54]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Heart diseases remain a major cause of mortality and morbidity worldwide. However, terminally differentiated human adult cardiomyocytes (CMs) possess a very limited innate ability to regenerate. Directed differentiation of human embryonic stem cells (hESCs) and induced pluripotent stem cells (iPSCs) into CMs has enabled clinicians and researchers to pursue the novel therapeutic paradigm of cell-based cardiac regeneration. In addition to tissue engineering and transplantation studies, the need for functional CMs has also prompted researchers to explore molecular pathways and develop strategies to improve the quality, purity and quantity of hESC-derived and iPSC-derived CMs. In this review, we describe various approaches in directed CM differentiation and driven maturation, and discuss potential limitations associated with hESCs and iPSCs, with an emphasis on the role of epigenetic regulation and chromatin remodeling, in the context of the potential and challenges of using hESC-CMs and iPSC-CMs for drug discovery and toxicity screening, disease modeling, and clinical applications.
    Full-text · Article · Aug 2013 · Stem Cell Research & Therapy
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Stem cell researchers in the United States have faced a quagmire of uncertainty due to multiple factors: the ethical divide over the use of embryos for research, the lack of clarity in federal guidelines governing this research, the restrictive patent situation surrounding the generation of new human embryonic stem (HES) cell lines; and the limits on types of research eligible for federal funding. In this commentary, we describe how recent advances in derivation of hES cell-like lines may allow at least some of these uncertainties to be resolved. More importantly, we suggest that the derivation of hES cell-like lines by morally acceptable methods would not only avoid the corrosive effects of a protracted ethical debate over stem cell research, but would also allow U.S. researchers to access federal funds and compete on a more level international playing field.
    Full-text · Article · Mar 2008 · Stem Cells and Development
  • [Show abstract] [Hide abstract]
    ABSTRACT: Human cell culture has become an essential component of biomedical research. The pluripotent phenotype, naturally occurring within the inner cell mass of the early embryo, confers the ability to develop into any cell type of interest. The exploitation of this ability in conjunction with modern genetic engineering tools holds great potential for analysing developmental and adult physiology and pathophysiology as well as for promising an exciting future for regenerative medicine. A broad range of gene delivery systems are available to researchers involved in pluripotent stem cell manipulation. Merits of viral and non-viral systems are driven primarily by the efficiency of stem cell gene transfer. Here, we review the use of viruses (primarily retroviruses, adenoviruses and lentiviruses) and recently optimised non-viral systems for stem cell gene transfer focusing on the recent work on human embryonic stem cells and induced pluripotent stem cells.
    No preview · Article · Dec 2008 · Drug Discovery Today Technologies
Show more